PTO Form 1581 (Rev 4/2000) |
OMB Control #0651-0009 (Exp. 06/30/2005) |
Extension Statement of Use Filing
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
76505310 |
LAW OFFICE ASSIGNED |
LAW OFFICE 108 |
MARK SECTION |
MARK |
LEENA |
OWNER SECTION (current) |
NAME |
Watson Pharmaceuticals, Inc. |
STREET |
311 Bonnie Circle |
CITY |
Corona |
STATE |
CA |
ZIP/POSTAL CODE |
928802882 |
COUNTRY |
US |
OWNER SECTION (proposed) |
NAME |
Watson Pharmaceuticals, Inc. |
STREET |
311 Bonnie Circle |
CITY |
Corona |
STATE |
CA |
ZIP/POSTAL CODE |
92880-2882 |
COUNTRY |
US |
GOODS AND/OR SERVICES SECTION |
INTERNATIONAL CLASS |
005 |
KEEP EXISTING GOODS AND/OR SERVICES |
YES |
EXTENSION SECTION |
EXTENSION NUMBER |
2 |
ONGOING EFFORT |
product development |
ALLOWANCE MAIL DATE |
02/17/2004 |
STATEMENT OF USE |
NO |
PAYMENT SECTION |
NUMBER OF CLASSES |
1 |
SUBTOTAL AMOUNT |
150 |
TOTAL AMOUNT |
150 |
SIGNATURE SECTION |
SIGNATORY FILE |
Signature |
SIGNATORY NAME |
David A. Buchen |
SIGNATORY POSITION |
Senior Vice President, General Counsel and Secretary |
FILING INFORMATION |
SUBMIT DATE |
Fri Jan 07 12:54:54 EST 2005 |
TEAS STAMP |
USPTO/ESU-XXX.XX.XXX.X-20
050107125454232080-765053
10-20053638c1fbba6c9dc138
f2722bb1e4bca-CC-1127-200
50107125335851181 |
PTO Form 1581 (Rev 4/2000) |
OMB Control #0651-0009 (Exp. 06/30/2005) |
Trademark/Service Mark Extension for Filing a Statement of Use
(15 U.S.C. Section 1051(d))
To the Commissioner for Trademarks:
MARK: LEENA
SERIAL NUMBER: 76505310
The applicant, Watson Pharmaceuticals, Inc., residing at 311 Bonnie Circle , Corona, CA US 92880-2882, requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89
in this application. The Notice of Allowance mailing date was 02/17/2004.
For International Class: 005, the applicant has a continued bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on or in connection with all of
the goods and/or services listed in the Notice of Allowance, or as subsequently modified.
This is the second extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods and/or services covered by
the extension request: product development.
A fee payment in the amount of $150 will be submitted with the form, representing payment for 1 class.
|
APPLICANT NAME: |
Watson Pharmaceuticals, Inc. |
MARK: |
LEENA |
Declaration
The undersigned being hereby warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. Section 1001, and that such willful false statements
and the like may jeopardize the validity of this document, declares that he/she is properly authorized to execute this document on behalf of the Owner; and all statements made of his/her own
knowledge are true and that all statements made on information and belief are believed to be true.
Signatory's Name: David A. Buchen
Signatory's Position: Senior Vice President, General Counsel and Secretary
Signatory File
Signature
RAM Sale Number: 1127
RAM Accounting Date: 01/07/2005
Serial Number: 76505310
Internet Transmission Date: Fri Jan 07 12:54:54 EST 2005
TEAS Stamp: USPTO/ESU-XXX.XX.XXX.X-20050107125454232
080-76505310-20053638c1fbba6c9dc138f2722
bb1e4bca-CC-1127-20050107125335851181
Go Back